| Name | 4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol |
|---|---|
| Synonyms |
Hexoprenalino [INN-Spanish]
Gynipral 4,4'-[1,6-hexanediylbis[imino(1-hydroxy-2,1-ethanediyl)]]bis-1,2-benzenediol Hexoprenaline [INN:BAN] Etoscol Esoprenalina [DCIT] Hexoprenalinum [INN-Latin] 1,2-Benzenediol,4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis Ginipral N,N'-bis[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]hexamethylenediamine (+/-)-Hexoprenaline |
| Description | Hexoprenaline is an orally active and selective β-adrenergic receptor agonist that dilates the bronchi. Hexoprenaline can be used in the study of bronchospasm, including asthma, bronchitis, and emphysema[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.302g/cm3 |
|---|---|
| Boiling Point | 707.8ºC at 760mmHg |
| Melting Point | 162-165° (hemihydrate) |
| Molecular Formula | C22H32N2O6 |
| Molecular Weight | 420.49900 |
| Flash Point | 186ºC |
| Exact Mass | 420.22600 |
| PSA | 145.44000 |
| LogP | 2.79740 |